Form 8-K - Current report:
SEC Accession No. 0001213900-21-042073
Filing Date
2021-08-12
Accepted
2021-08-12 16:40:06
Documents
15
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea145589-8k_citiuspharma.htm   iXBRL 8-K 36666
2 PRESS RELEASE, DATED AUGUST 12, 2021 ea145589ex99-1_citiuspharma.htm EX-99.1 100305
3 GRAPHIC ex99-1_001.jpg GRAPHIC 13858
  Complete submission text file 0001213900-21-042073.txt   387344

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ctxr-20210812.xsd EX-101.SCH 3746
5 XBRL DEFINITION FILE ctxr-20210812_def.xml EX-101.DEF 27691
6 XBRL LABEL FILE ctxr-20210812_lab.xml EX-101.LAB 36698
7 XBRL PRESENTATION FILE ctxr-20210812_pre.xml EX-101.PRE 26309
8 EXTRACTED XBRL INSTANCE DOCUMENT ea145589-8k_citiuspharma_htm.xml XML 5180
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 211168251
SIC: 2834 Pharmaceutical Preparations